Catalyst Wire Dossier Catalyst Wire Dossier

Chimeric Monoclonal Antibodies to Shiga Toxins 1 and 2

· Thallion Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Chimeric Monoclonal Antibodies to Shiga Toxins 1 and 2, covering 2013-04-25 to 2013-04-25. Get the full timeline:

Most recent: Clinical Trial Update: Study of Chimeric Monoclonal Antibodies to Shiga Toxins 1 and 2 [Phase 2]

See pricing